Exim Bank and JBIC sign $100 million loan agreement to support healthcare sector


The Export-Import Bank of India (Exim Bank) announced on Monday that it has signed a $100 million loan agreement with the Japan Bank for International Cooperation (JBIC), as well as three Japanese private financial institutions – MUFG Bank Ltd. , Bank of Kyoto Ltd and Hachijuni Bank Ltd – aimed at supporting India’s healthcare sector in the fight against COVID-19.

The deal was signed on Monday on the sidelines of the Quad Leaders’ Summit, Exim Bank said in a statement.

“The purpose of this facility is to support the Indian healthcare sector related to the fight against COVID-19, including but not limited to vaccine manufacturers, pharmaceutical companies, medical equipment manufacturers personal protection, medical oxygen or other medical devices, hospitals and other related activities.” It said.

The development finance institution supports the health sector and all segments of the pharmaceutical value chain.

Apart from supporting the domestic expansion projects of companies in these sectors, the bank has also supported the overseas efforts of various Indian companies in the healthcare sector, pharmaceutical companies and biosimilar/biopharmaceutical companies (including science life), among others.

In addition, it has supported research and development, new product development and other related fields, he added.

(Only the title and image of this report may have been edited by Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear reader,

Business Standard has always endeavored to provide up-to-date information and commentary on developments that matter to you and that have wider political and economic implications for the country and the world. Your constant encouragement and feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these challenging times stemming from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative opinions and incisive commentary on relevant topical issues.
However, we have a request.

As we battle the economic impact of the pandemic, we need your support even more so that we can continue to bring you more great content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of bringing you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism we are committed to.

Support quality journalism and subscribe to Business Standard.

digital editor


Comments are closed.